Q2 2025 Haemonetics Corp Earnings Call Transcript
Good day. And thank you for standing by. Welcome to the second-quarter, 2025 Haemonetics Corporation earnings conference call. (Operator Instructions)
I would now like to hand the conference over to your first speaker, Olga Guyette. Please go ahead.
Good morning everyone. Thank you for joining us for Haemonetics second-quarter, fiscal year 2025 conference call and webcast. I'm joined today by Chris Simon, our CEO and James D Arecca, our CFO. This morning, we posted our second-quarter, fiscal year 2025 results to our Investor Relations website along with our fiscal year 2025 guidance.
Before we begin, just a quick reminder that all revenue growth rates discussed today are organic unless specified otherwise and exclude the impact of currency fluctuation and acquisition. Our organic revenue growth guidance for fiscal year 2025 incorporates 15 weeks of revenue from OpSens due to the acquisition closing date being in December 2023.
We'll also refer to other non-GAAP financial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |